Background: Systematic reviews of fish and fish oil supplements have reported modest reductions in blood pressure (BP). Many of the trials included in these reviews used high doses of fish oil and most were of short duration. Method: Between 1983 and 1987 2033 men under the age of 70, who had recently suffered a myocardial infarction, were enrolled in a 2-year trial of dietary advice-the Diet and Reinfarction Trial (DART). Participants were randomised in a factorial design to receive intensive advice to eat more fish, less fat or more fibre. Those men randomised to receive fish advice were encouraged to eat two portions of fatty fish each week.
Introduction
Systematic reviews of trials of fish or fish oil supplements have reported modest reductions in blood pressure (BP). 1, 2 In the review by Morris et al 2 all placebo controlled trials were included, while in the review by Appel et al 1 only trials in healthy subjects not on antihypertensive medication were included. Many trials are included in both reviews. In the 11 trials in normotensives reviewed by Appel et al the estimated reduction in systolic BP was Ϫ1.0 mm Hg (95% CI Ϫ2.0, 0.0) and the reduction in diastolic BP was Ϫ0.5 mm Hg (95% CI Ϫ1.2, 0.2). 1 In the six trials of hypertensives the estimated reduction in systolic BP was Ϫ5.5 mm Hg (95% CI Ϫ8.1, Ϫ2.9) and the reduction in diastolic BP was Ϫ3.5 mm Hg (95% CI Ϫ5.0, Ϫ2.1).
1 Most of the trials included in the reviews, used high intakes of fish or high doses of fish oil and most were of short duration (13 of 17 in the review by Appel et al ran for less than 3 months). 1 In the nine trials, in a total of 614 subjects reviewed by Morris et al where the dose of -fatty acids was р3 g per day, the estimated reduction in systolic BP was Ϫ1.3 mm Hg (95% CI Ϫ4.8, 2.2) and the reduction in diastolic BP was Ϫ0.7 mm Hg (95% CI Ϫ1.9, 0.5). 2 Most trials in patients with existing coronary disease have reported a larger reduction in BP than those carried out in healthy subjects. 2 In the four trials in a total of 88 subjects with cardiovascular disease reviewed by Morris et al the estimated reduction in systolic BP was Ϫ6.3 mm Hg (95% CI Ϫ17.0, 4.5) and the reduction in diastolic BP was Ϫ2.9 mm Hg (95% CI Ϫ6.4, 0.6). 2 It is thus not clear whether a modest increase in fish consumption has any long-term effect on BP, particularly in people with pre-existing coronary heart disease. In an attempt to answer this question we examined the effect of fish advice on BP at 6 months and 2 years in around 2000 men who had recently recovered from a myocardial infarction.
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Materials and methods
The recruitment and methods of the Diet and Reinfarction Trial (DART) have been described in detail previously. [3] [4] [5] Briefly, from January 1983 until January 1987, 2033 men aged under 70 who had sur-vived a myocardial infarction were enrolled in the study. They were recruited from 21 hospitals in South Wales and the South West of England. Wards were visited each week and men under 70 who had suffered an acute myocardial infarction, according to World Health Organisation criteria, were identified. 3 Potential participants were excluded for the following reasons: if they already intended to eat one of the study diets (n = 1044); if they had serious illnesses such as diabetes, cancer or renal failure (n = 443); if they were being considered for cardiac surgery (n = 58); if they planned to live outside the study area (n = 75); if they were participating in a local cohort study (n = 22); if they were averse to one of the proposed diets (n = 115); if they refused (n = 214) or if they died before randomisation (n = 237). A further 130 were excluded but the reason for exclusion was not recorded. 3 Subjects were visited at home by a doctor shortly after discharge from hospital. Past history of disease, self-reported smoking habits, alcohol intake and current drug treatment were recorded. Blood pressure was measured using either an automatic BP machine (for men admitted to hospitals in Wales) or using a mercury sphygmomanometer (for men admitted to hospitals in England). Height and weight were recorded and body mass index (weight/ (height × height) calculated.
Subjects were then seen in their homes, usually with their wives, by a nutritionist and were randomly allocated to one of the study diets in a factorial design. Randomisation was not stratified by age, body weight or any other subject characteristics. Participants could be assigned to one of eight dietary regimes-fat advice, fish advice, fibre advice, fat and fish, fat and fibre, fish and fibre, all three or no advice. In addition, all smokers were advised to stop and those with a body mass index over 30 were given weight-reducing advice regardless of their allocated diet. The dietary advice was repeated and intensive. Each subject was given verbal advice and a diet sheet, which summarised one of the eight regimes. Those allocated to receive no advice were given a sensible eating sheet, which did not include advice on any of the proposed interventions. Subjects were visited again by the nutritionist after 1 month, 3 months and 6 months and given recipes where this was deemed appropriate. Thereafter they were contacted at 3-monthly intervals until 2 years after entry to the trial. Those randomised to fish advice were encouraged to eat two portions of fatty fish (eg, mackerel, herring, kipper, pilchards, sardines, salmon or trout) a week and as much other fish as they could manage. Those unwilling to eat this amount of fish were offered fish oil capsules as a partial or total replacement for fatty fish (MaxEPA), which contained 1-3 g of oil. [3] [4] [5] Subjects were visited again, by the same doctor, 6 months and 2 years after they were randomised. Their current medication was recorded, they were weighed and their BP measured using the same device. Compliance with the different diets was also formally assessed at 6 months and 2 years. A validated food frequency questionnaire was administered to all subjects. In addition a random sample of 459 men was asked to complete a 7-day weighed dietary record at 6 months and 2 years.
Intake in eicosapentaenoic acid was 0.33 g per day in the fish advice group and 0.10 g per day in those not given fish advice. Around 14% of those in the fish arm took fish oil capsules at 6 months and 22% at 2 years. [3] [4] [5] The protocol was approved by the Ethics Committees of the participating hospitals. Informed consent was obtained from all subjects.
The data were analysed using STATA 5.0. 6 Analyses concentrated on comparisons between men given and not given fish advice. Differences in weight, smoking and medication at 6 months and 2 years were assessed using chi-squared and unpaired t-tests. Least squared regression was used to compare changes from baseline in BP at 6 months and 2 years and to adjust for the effects of possible confounding factors.
Results
The baseline characteristics of those randomised to receive advice to eat more fish and those randomised to receive no fish advice are shown in Table 1 . The groups were very similar at baseline.
The numbers of men completing the trial and the systolic and diastolic BP at baseline of men who completed the trial, died or were lost to follow-up are shown in Table 2 . As previously reported 5 fewer men in the fish advice arm had died at 6 months and 2 years. Of participants who were alive, BP measurements were available for the majority of men in each arm of the trial.
To see if men in the fish advice arm behaved or were treated differently from those not given fish advice we looked at reported smoking, use of antihypertensive drugs, use of anti-anginal drugs or measured weight at either 6 months or 2 years. There were no substantial differences between the two arms. These data are shown in Table 3 . The crude and adjusted mean differences in systolic and diastolic BP at 6 months and 2 years are shown in Table 4 . The observed differences in BP were small and none were significantly different from zero. Additional adjustment for past history of hypertension, smoking at baseline, weight at baseline, antihypertensive and anti-anginal drugs used at baseline, smoking at 6 months or 2 years, weight at 6 months or 2 years and antihypertensive and anti-anginal drugs at 6 months or 2 years had little effect on these differences (data not shown). As the systematic review by Appel et al 1 had suggested the effect of fish supplementation was more marked in hypertensives we looked at the adjusted mean difference in systolic and diastolic BP at 6 months and 2 years in a number of sub-groups. These data are shown in Table 5 . There was no clear reduction in BP in men with higher BP.
Exclusion of data from men admitted to hospital in England, where BP was measured using a mercury sphygmomanometer, did not alter the observed differences in BP (data not shown).
Discussion
We found no evidence of a reduction in either systolic or diastolic BP at 2 years in this large randomised trial of fish advice in men with a recent past history of myocardial infarction. The 95% confidence intervals of our findings suggest that a modest increase in fish intake produces no more than a 1.3 mm Hg/0.9 mm Hg drop in systolic and diastolic BP respectively. In fact our results are also consistent with a 2.1 mm Hg/1.3 mm Hg rise in systolic and diastolic BP respectively with increased fish intake.
There are several possible reasons why we may have failed to observe a reduction in BP in those randomised to receive fish advice. First, if the men allocated to receive fish advice were less likely to seek or to be offered treatment for high BP this might explain the observed lack of effect if coupled with a genuine reduction in BP in this group. This seems unlikely as there were no marked differences in reported use of antihypertensives and adjustment in regression models for reported antihypertensive medication made little difference to the observed effect. Second, as the men allocated to fish advice were more likely to survive this may have introduced a differential bias if fish protected men with higher blood pressures. The baseline BP of men who subsequently died was similar in both groups making this explanation unlikely. Third, men allocated to fish advice may have made other lifestyle changes, such as reducing their levels of physical activity or increasing their alcohol intake, that counterbalanced the putative BP-lowering effect of fish. Though we cannot discount this explanation entirely the fact that there was no sizeable difference in subsequent weight, smoking habits, alcohol intake (data not shown) and prescribed medication makes it seem doubtful. Fourthly, it is possible that men receiving fish advice increased their intake of smoked and salted fish. If this was the case the increased salt intake might increase BP and offset any BP-lowering effect of the fish. There was, however, no difference in estimated sodium intake in the men who completed 7-day food diaries. At 6 months the estimated intake of sodium in those receiving fish advice was 2.5 g per day compared with 2.6 g per day in those not receiving fish advice -difference of Ϫ0.1 g per day in those receiving fish advice (95% CI Ϫ0.4 g per day to 0.2 g/day). Finally compliance may have been poor meaning that there was little difference in fish intake between the two groups. Though dietary estimates of fish oil intake suggest that compliance was good, no objective measures of compliance were collected. However, the fact that men who could not tolerate the fish regime asked to receive fish oil capsules suggests that they were trying to comply with the advice. Also, the observation that platelet function appeared to be related to ecosapentaenoic acid intake 7 and the fact that mortality advantages were observed in those who received fish advice both support the notion that compliance was good. 5 Furthermore, the measurement of BP was relatively crude. It was measured only once at each visit and a clearly defined protocol was not used. The observers were, however, blind to the participants' allocated diet. Thus any measurement error should be random rather than systematic as the technique used, the device used and the person measuring the BP were not contingent on the dietary advice the subject received. Such random error will tend to obscure real associations rather than generate spurious associations. In spite of this lack of precision in BP measurement the large size of the study means that it would have been able to detect even modest differences in BP in those offered fish advice. We calculated, before we embarked on this analysis, that this study would have 90% power to detect a difference of around 2.6 mm Hg in systolic BP and around 1.8 mm Hg in diastolic BP at the 5% level. Thus, we would have adequate power to detect the differences in BP reported in previous trials of fish (or fish oil) supplementation in subjects with cardiovascular disease.
Other trials of fish, or fish oil supplementation, and BP have been shorter and smaller than DARTnone that we are aware of has run for over 6 months. 1, 2 This study contains more participants than the pooled analyses carried out by Morris et al that included 1356 subjects from 31 trials 2 and by Appel et al that included 1019 subjects from 17 trials. 1 The next largest trial reported to date studied 350 normotensives who were randomised to receive fish oil capsules, delivering a dose of 2.1 g of eicosapentaenoic acid per day, or placebo. This was substantially more than in DART where the estimated intake in those receiving fish advice was 0.33 g per day. At the end of 24 weeks the mean difference in systolic BP was Ϫ0.20 mm Hg and Ϫ0.60 mm Hg for diastolic BP. These results of this study are very similar to those we observed in DART. So is the pooled effect reported by Morris et al for studies where the dose of -fatty acids was р3 g per day, which was a mean difference in systolic BP of Ϫ1.30 mm Hg and a mean difference in diastolic BP of Ϫ0.7 mm Hg. The modest difference in fish intake in DART might explain the lack of effect in our data. The consistency of our results with those of the only other large trial and the pooled estimate for trials of similar dose suggest two things. First, that modest intake of fish or fish oil has little effect on BP. This is reassuring as there are a number of instances where large trials have not confirmed the results of previous meta-analyses based on small trials. 8 Second, this consistency suggests that our data (despite the imprecision of the BP measurement) are a reliable estimate of the true underlying effect. Furthermore, the fact that the small (non-significant) reduction in BP observed at 6 months disappeared completely by 2 years suggests that the effect of increased intake of fish or fish oils, even in high doses, may be evanescent.
This observed lack of effect is consistent with the observational data, which have failed to find substantially lower blood pressures in communities or individuals consuming large quantities of fish. [9] [10] [11] [12] [13] However, fewer men allocated to eat fish died over the 2 years of the trial. 5 This observed protective effect is consistent with the results from observational studies.
14 The protective effect of fish may be mediated through a number of mechanisms other than BP. These include: an effect on triglycerides (by inhibition of hepatic synthesis), a reduction in thrombotic tendency of platelets (by a reduction of ecosanoid synthesis), a reduction in platelet aggregation (through effects on prostaglandin metabolism) and a reduction in ischaemia-induced ventricular fibrillation. 15, 16 Though increased fish intake may not reduce BP, hypertensives should be advised to eat more fish (particularly fatty fish) to reduce their risk of death, but receive other treatment for their BP.
